Found 107 matching trials
A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19. PHASE3 This is a phase III clinical study to assess the safety, tolerability and i...
Show More Location
Hospital de Niguarda
Learn More & Join Trial
Neutralizing Power of Serum Antibodies - 2 NA Severe forms of COVID-19 and Monkeypox affect immunocompromised and comorbi...
Show More Learn More & Join Trial
Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) PHASE1 The primary objective is to assess the safety and tolerability of samRNA va...
Show More Location
Newtown Clinical Research Centre
Learn More & Join Trial
Assessing Immune Response of Different COVID-19 Vaccines in Older Adults PHASE2 This is a randomised controlled, adaptive, multicentre Phase II protocol ev...
Show More Location
University Hospital Cologne
Learn More & Join Trial
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries. N/A Background: Scarce information exists in relation to the comparison of sero...
Show More Location
Hospital Clinica Nova de Monterrey
Learn More & Join Trial
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals PHASE2 This is a Phase 1/2/3, randomized, placebo-controlled, observer-blind, dose...
Show More Location
North Alabama Research Center, LLC
Learn More & Join Trial
Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers N/A With the unprecedented morbidity of the COVID-19 pandemic, the vaccine effe...
Show More Location
Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine
Learn More & Join Trial
A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 PHASE2 Primary Immunogenicity Objective:Cohort 1: GMTs of SARS-CoV-2 Omicron and r...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years PHASE1 This study is a randomized, double-blinded, and placebo-controlled phase Ib...
Show More Location
West China Second University Hospital, Sichuan University / West China women's and children's Hospital
Learn More & Join Trial
Vaccination Against COVID-19 in Cancer NA This study will collect information on immune response and adverse events a...
Show More Learn More & Join Trial